Holistic Management of Atopic Dermatitis In a 12 Years Old Child at Kota Karang Public Health Center Using Family Medicine Approach
DOI:
https://doi.org/10.53089/medula.v13i1.534Keywords:
Atopic dermatitis, family medicine managementAbstract
Atopic dermatitis also known as eczema is the most common form of chronic dermatitis. This disease is generally synonymous with itching which is characterized by dry skin, chronic lesions, and lichenification. Atopic dermatitis is believed to be associated with other forms of IgE disorders such as allergic rhinitis, asthma, and food intolerance. This disease results in a high rate of morbidity and its prevalence has increased in recent decades. The study conducted is a case report. Data were obtained through history taking and physical examination by conducting home visits. The assessment is carried out based on a qualitative diagnosis, process, and visit. Based on the examination, the patient was a 12 year old girl with atopic dermatitis. Knowledge of patients and families about the disease is very limited. Education and intervention provided to patients and families about atopic dermatitis and risk factors that can trigger the occurrence of this disease. On internal factors in cases such as genetic factors, age factors, and ignorance of the originator. External factors are the lack of family knowledge about atopic dermatitis, its complications and the environment that has many allergens. Pharmacological and non-pharmacological interventions are carried out in the form of education in preventing the onset of atopic dermatitis symptoms in patients. In the evaluation of increasing patient compliance to avoid risk factors and family knowledge about patient care. Services with a family medicine approach in pharmacological and non-pharmacological therapy are able to solve health problems and improve the patient's quality of life.
References
Tabri F. Aspek Imunogenetik DA pada Anak. Makassar : Jurnal Universitas Hasanuddin. 2004; vol.2:85-110.
Archietobias MA, Hendra TS, Novita C. Hubungan antara Derajat Keparahan DA dengan Kualitas Hidup Pasien di RSUD Abdul Moeloek Lampung. Bandar Lampung : Jurnal Majority Fakultas Kedokteran Universitas Lampung. 2014; vol.3:no.2.
Moore MM, Rifas SL, Rich JW, Kleinman KP, Camargo CA. Perinatal Predictors of Atopic Dermatitis Occurring in The First Six Months of Life. Medical Journal : ncbi. 2004; vol.113:no.3. p. 468–474.
Won J. Atopic Dermatitis (AD) is Marked by Elevated Levels of Immunoglobulin; 2007 [diakses tanggal 28 April 2014]. didapat dari : http://onlinelibrary.wiley.com
Indrawanto IS. Hubungan antara Beratnya Manifestasi DA dengan Tingginya Skala Kepribadian Cemas pada Tes MMPI di RSUD Dr.Soetomo. Surabaya : RS Dr.Soetomo. 2012; vol.6:no.12.
Soebaryo RW. Etiologi dan Patogenesis DA. Dalam: Boediardja SA, Sugito TL, Rihatmadja R, editor. Dermatitis pada bayi dan anak. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2004. p. 1-8.
Natalia, Sri LM, Triana A. Perkembangan Terkini pada Terapi DA. Jakarta : Jurnal Medis Indonesia Departemen Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Indonesia.
Boediardja SA. Etiopatogenesis Beberapa Dermatitis pada Bayi dan Anak. Dalam: Djajakusumah TS, ed. Antiinflamasi Topikal pada Pengobatan Dermatitis Bayi dan Anak. Jakarta: Balai Penerbit FK UI; 2006. p. 11-28.
Abramovits W, Berman B, Cohen DE, Guttman SE, Lebwohl MG, Mancini AJ, Rosso, JQD, Schachner LA. Pathways to Managing Atopic Dermatitis. The Journal of Clinical and Aesthetic Dermatology. 2013; vol.6:no.7.
Patrick F. Dermatology in General Medicine 7th Edition Volume one. United States : The McGraw-Hill Companies; 2008. p. 146-158.
Bieber T. Mechanisms of Disease Atopic Dermatitis. Journal Medicine : NEJM. 2008; 358:1483-1494.
Zulkarnain I. Manifestasi Klinis dan Diagnosis DA. Dalam: Boediardja SA, ed. DA. Jakarta: Balai Penerbit FK UI; 2009. p. 21-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.